Core Scientific Inc (CORZ) is expected to grow earnings and revenues in the years ahead

Core Scientific Inc [CORZ] stock is trading at $15.27, up 1.80%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CORZ shares have gain 12.28% over the last week, with a monthly amount drifted -4.74%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Core Scientific Inc [NASDAQ: CORZ] stock has seen the most recent analyst activity on January 21, 2025, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $24. Previously, ROTH MKM started tracking the stock with Buy rating on November 15, 2024, and set its price target to $25.50. On October 28, 2024, Jefferies initiated with a Buy rating and assigned a price target of $19 on the stock. Macquarie started tracking the stock assigning a Outperform rating and suggested a price target of $16 on September 25, 2024. Canaccord Genuity initiated its recommendation with a Buy and recommended $16 as its price target on September 23, 2024. Needham started tracking with a Buy rating for this stock on September 04, 2024, and assigned it a price target of $16. In a note dated July 17, 2024, B. Riley Securities upgraded an Buy rating on this stock but restated the target price of $13.

Core Scientific Inc [CORZ] stock has fluctuated between $2.61 and $18.63 over the past year. Currently, Wall Street analysts expect the stock to reach $17.83 within the next 12 months. Core Scientific Inc [NASDAQ: CORZ] shares were valued at $15.27 at the most recent close of the market. An investor can expect a potential return of 16.76% based on the average CORZ price forecast.

Analyzing the CORZ fundamentals

Core Scientific Inc [NASDAQ:CORZ] reported sales of 557.68M for the trailing twelve months, which represents a drop of -15.54%. Gross Profit Margin for this corporation currently stands at 0.28% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at -2.23%, and Net Profit Margin reading is -2.23%. To continue investigating profitability, this company’s Return on Assets is posted at -1.35, Equity is 1.83 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.78.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.79 points at the first support level, and at 14.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.67, and for the 2nd resistance point, it is at 16.08.

Ratios To Look Out For

For context, Core Scientific Inc’s Current Ratio is 3.63. In addition, the Quick Ratio stands at 3.63 and the Cash Ratio stands at 3.31. Considering the valuation of this stock, the price to sales ratio is 7.65.

Transactions by insiders

Recent insider trading involved Sullivan Adam Taylor, Chief Executive Officer, that happened on Jan 02 ’25 when 88380.0 shares were sold., DUCHENE TODD M completed a deal on Jan 02 ’25 to sell 0.13 million shares. Meanwhile, DUCHENE TODD M sold 2949.0 shares on Jan 03 ’25.

Related Posts